Biofrontera Inc (BFRI) Stock Price, Quote & News

Company Profile

Biofrontera Inc., a biopharmaceutical company, engages in the commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's products are used for the treatment of actinic keratoses, which are pre-cancerous skin lesions, as well as impetigo, a common skin infection. It offers Ameluz, a prescription drug for use in combination with the RhodoLED lamp series, for photodynamic therapy for the lesion-directed and field-directed treatmen...

Industry: Drug Manufacturers - Specialty & Generic

Sector: Healthcare

Phone: 781 245 1325

Website: www.biofrontera-us.com

Address:

120 Presidential Way, Suite 330, Woburn, United States

NextBigRun Jul. 7 at 5:35 AM

$DRCT $BFRI Sick charts. ready to go

0 · Reply

Bulltrader988 Jul. 4 at 7:16 PM

$BFRI run finally 👃👀

0 · Reply

Stereo Jul. 4 at 5:05 PM

$BFRI it all depends on the Q4 now. They’ve secured enough runway for the year with this merger deal & they can always appeal for more time if they don’t clear $1.00 by November. We’ve gone from bearish territory with all the prior delays to cautiously bullish. So long as there are no hiccups with the upcoming clinical trials it should be smooth sailing, but if there are hiccups be prepared for a rocky road. I’m optimistic. If these clinical trials clear, we soar.

0 · Reply

Apache3000 Jul. 1 at 1:24 PM

$BFRI Bipolar stock

0 · Reply

Bulltrader988 Jul. 1 at 1:20 PM

$BFRI 👃👀 https://www.tipranks.com/news/company-announcements/biofrontera-finalizes-acquisition-of-u-s-ameluz-rights?utm_source=webullapp.com&utm_medium=referral

0 · Reply

Imran26 Jun. 30 at 8:30 PM

$BFRI Agree The royalty is/was 25% not 35% and the reduction (is exchange for 10% dilution) is after doing 5 dilutive deals this past 6 months. They managed to burn $30 million in 6 months. They lied about Q4 revenue spilling into Q1. This is all about Hermann ’s employment. Weird why would AIGH etc not get it, after such a horrible year

0 · Reply

MOOSEN Jun. 30 at 7:32 PM

$BFRI INTRIGUING.

0 · Reply

ivo98 Jun. 30 at 7:10 PM

$BFRI don't trap in the fake news. Only for creating a hype. License and supply agreement wasn't 35% as in the fake news . See 8-K filing date 2024-02-20.

0 · Reply

Bulltrader988 Jun. 30 at 6:50 PM

$BFRI 👃👀 https://www.tipranks.com/news/company-announcements/biofrontera-restructures-u-s-rights-with-11m-investment?utm_source=webullapp.com&utm_medium=referral

0 · Reply

Bulltrader988 Jun. 30 at 6:26 PM

$BFRI PT raised from $8 to $10 👃👀 https://www.tipranks.com/news/the-fly/biofrontera-inc-price-target-raised-to-10-from-8-at-roth-capital-thefly?utm_source=webullapp.com&utm_medium=referral

0 · Reply

Biofrontera Inc. Announces Major Restructuring of Relationship With Biofrontera AG Backed By $11 Million Investment

Jun 11, 2025, 3:00 PM EDT - 26 days ago

BIOFRONTERA INC. IS NEGOTIATING FUNDAMENTAL CHANGES TO ITS COOPERATION WITH BIOFRONTERA AG

Jun 3, 2025, 2:30 PM EDT - 4 weeks ago

Biofrontera Inc. Announces Patent for Propylene Glycol-Free Formula of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% Now Listed in FDA Orange Book

May 16, 2025, 3:36 PM EDT - 7 weeks ago

Biofrontera Inc. (BFRI) Q1 2025 Earnings Call Transcript

May 15, 2025, 5:09 PM EDT - 7 weeks ago

Biofrontera Inc. Reports First Quarter 2025 Financial Results and Provides a Business Update

May 15, 2025, 12:17 PM EDT - 7 weeks ago

Biofrontera Inc. Announces New Patent Protection on Ameluz® until 2043 and the Completion of Patient Enrollment in Phase 2b Study of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% for the Treatment of Moderate to Severe Acne Vulgaris

May 6, 2025, 12:45 PM EDT - 2 months ago

Biofrontera Inc. to Report First Quarter FY 2025 Financial Results on May 15, 2025

May 1, 2025, 2:38 PM EDT - 2 months ago

Biofrontera and Almirall Launch the Hats On Challenge to Raise Awareness and Support for Actinic Keratosis

Mar 21, 2025, 11:20 AM EDT - 3 months ago

Biofrontera Inc. (BFRI) Q4 2024 Earnings Call Transcript

Mar 21, 2025, 8:00 AM EDT - 3 months ago

Biofrontera Inc. Reports Record Fiscal Year 2024 Financial Results and Provides a Business Update

Mar 18, 2025, 9:30 AM EDT - 3 months ago

Biofrontera Inc. Announces Completion of Patient Enrollment in Phase 3 Study of Ameluz® (aminolevulinic acid HCI) Topical Gel, 10% for the Treatment of Actinic Keratoses on the Extremities, Neck and Trunk

Mar 11, 2025, 10:00 AM EDT - 4 months ago

Biofrontera Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on March 21, 2025

Jan 8, 2025, 9:50 AM EST - 6 months ago

Biofrontera Inc. Announces Achievement of Key Milestone In Phase 3 Study Of Ameluz®-Photodynamic Therapy (PDT) In The Treatment Of Superficial Basal Cell Carcinoma (sBCC)

Dec 23, 2024, 9:30 AM EST - 7 months ago

Biofrontera Inc. Announces 100 RhodoLED® XL Machines Now Placed in US Market

Dec 3, 2024, 11:00 AM EST - 7 months ago

Biofrontera Inc. to Present at The Benchmark Company's Upcoming Discovery One-on-One Investor Conference

Nov 22, 2024, 9:10 AM EST - 8 months ago

Biofrontera Inc. Closes a $4.2 Million Senior Secured Convertible Note

Nov 14, 2024, 3:02 PM EST - 8 months ago

Biofrontera Inc. (BFRI) Q3 2024 Earnings Call Transcript

Nov 13, 2024, 5:15 PM EST - 8 months ago

Biofrontera Inc. Reports Third Quarter and Nine-Month 2024 Financial Results and Provides Business Update

Nov 1, 2024, 11:55 AM EDT - 8 months ago

Biofrontera Inc. to Report Third Quarter Financial Results on November 13, 2024

Oct 31, 2024, 10:32 AM EDT - 8 months ago

Biofrontera Inc. Announces Highly Significant Results In Phase 3 Study Of Ameluz®-Photodynamic Therapy (PDT) Regarding The Treatment Of Superficial Basal Cell Carcinoma (sBCC)

Oct 14, 2024, 10:30 AM EDT - 9 months ago

Biofrontera Inc. Announces Database Lock Of Phase 3 Study Of Ameluz®-Photodynamic Therapy (PDT) In The Treatment Of Superficial Basal Cell Carcinoma (sBCC)

Oct 7, 2024, 8:45 AM EDT - 9 months ago

FDA Approves Use of Up To Three Tubes of Biofrontera Inc.'s Ameluz (aminolevulinic acid HCI) Topical Gel, 10% In One Treatment

Sep 25, 2024, 10:45 AM EDT - 10 months ago

Biofrontera to Present at the 3rd Annual ROTH Healthcare Opportunities Conference

Aug 15, 2024, 1:34 PM EDT - 11 months ago

Biofrontera Inc. (BFRI) Q2 2024 Earnings Call Transcript

Aug 14, 2024, 4:30 PM EDT - 11 months ago

Biofrontera Inc. Reports Second Quarter 2024 Financial Results and Provides a Business Update

Aug 9, 2024, 10:00 AM EDT - 11 months ago

Biofrontera Inc. to Report Second Quarter Financial Results on August 14, 2024

Jun 24, 2024, 8:30 AM EDT - 1 year ago

Biofrontera Announces the Launch of a New, FDA-Approved Red Light Source, the RhodoLED® XL Lamp

May 16, 2024, 2:44 PM EDT - 1 year ago

Biofrontera Inc. (BFRI) Q1 2024 Earnings Call Transcript

May 15, 2024, 4:45 PM EDT - 1 year ago

Biofrontera Inc. Reports First Quarter 2024 Financial Results and Provides a Business Update

May 6, 2024, 10:30 AM EDT - 1 year ago

Biofrontera Inc. to Report First Quarter 2024 Financial Results on May 15, 2024

May 3, 2024, 8:50 AM EDT - 1 year ago

Biofrontera Announces Achievement of Two Milestones Associated with Series B-3 Convertible Preferred Stock Warrants

Mar 26, 2024, 4:30 PM EDT - 1 year ago

Biofrontera Inc. Announces 2024 Annual Meeting of Stockholders and Deadlines for Submission of Stockholder Proposals

Mar 18, 2024, 12:13 PM EDT - 1 year ago

Biofrontera Inc. (BFRI) Q4 2023 Earnings Call Transcript

Mar 15, 2024, 8:25 PM EDT - 1 year ago

CORRECTION: Biofrontera Inc. Reports Record Fiscal Year 2023 Financial Results and Provides a Business Update

Mar 15, 2024, 6:10 PM EDT - 1 year ago

Biofrontera Inc. Reports Record Fiscal Year 2023 Financial Results and Provides a Business Update

Mar 8, 2024, 9:00 AM EST - 1 year ago

Biofrontera Inc. to Report Fourth Quarter and Full Year 2023 Financial Results on March 15, 2024

Mar 5, 2024, 7:30 AM EST - 1 year ago

Medicus Pharma Ltd. Announces Appointment of Erica Monaco as Chief Operating Officer

Feb 23, 2024, 8:40 AM EST - 1 year ago

Biofrontera Inc. Announces Closing of Private Placement of up to $16.0 Million Priced at Market per Nasdaq Rules

Feb 20, 2024, 8:10 AM EST - 1 year ago

Biofrontera Inc. Announces Restructuring of Supply Agreement with Biofrontera AG

Feb 20, 2024, 8:05 AM EST - 1 year ago

Biofrontera Inc. Announces Private Placement of Up To $16.0 Million Priced at Market per Nasdaq Rules

Feb 5, 2024, 5:15 PM EST - 1 year ago

Biofrontera Inc. Announces FDA Filing of Supplemental New Drug Application for Ameluz(R) to Permit Up to Three Tubes Per Use

Jan 11, 2024, 4:15 PM EST - 1 year ago

Biofrontera Inc. Announces Preliminary Revenues for the Fourth Quarter and Full Year 2023

Nov 10, 2023, 1:54 PM EST - 1 year ago

Biofrontera Inc. (BFRI) Q3 2023 Earnings Call Transcript

Nov 9, 2023, 5:10 PM EST - 1 year ago

Biofrontera Inc. Reports Third Quarter 2023 Financial Results and Provides a Business Update

Nov 3, 2023, 8:30 AM EDT - 1 year ago

Biofrontera Inc. to Report Third Quarter 2023 Financial Results on November 9 and Hold Conference Call on November 10

Oct 31, 2023, 8:01 AM EDT - 1 year ago

Biofrontera Inc. Announces $4.5 Million Registered Direct Offering Priced At-the-market Under NASDAQ Rules

Oct 10, 2023, 9:00 AM EDT - 1 year ago

Biofrontera Inc. Receives FDA Approval for New Formulation of Ameluz(R)

Oct 5, 2023, 9:00 AM EDT - 1 year ago

Biofrontera Inc. to Participate in the Roth MKM 2023 Healthcare Opportunities Conference and the 43rd Annual Fall Clinical Dermatology Conference

Oct 4, 2023, 8:30 AM EDT - 1 year ago

Biofrontera Inc. Announces Preliminary Third Quarter Revenues

Aug 29, 2023, 8:00 AM EDT - 2 years ago

Biofrontera Inc. Appoints Samantha Widdicombe to Support Commercial Relationships with Strategic Customer Accounts

NextBigRun Jul. 7 at 5:35 AM

$DRCT $BFRI Sick charts. ready to go

0 · Reply

Bulltrader988 Jul. 4 at 7:16 PM

$BFRI run finally 👃👀

0 · Reply

Stereo Jul. 4 at 5:05 PM

0 · Reply

Apache3000 Jul. 1 at 1:24 PM

$BFRI Bipolar stock

0 · Reply

Bulltrader988 Jul. 1 at 1:20 PM

$BFRI 👃👀 https://www.tipranks.com/news/company-announcements/biofrontera-finalizes-acquisition-of-u-s-ameluz-rights?utm_source=webullapp.com&utm_medium=referral

0 · Reply

Imran26 Jun. 30 at 8:30 PM

0 · Reply

MOOSEN Jun. 30 at 7:32 PM

$BFRI INTRIGUING.

0 · Reply

ivo98 Jun. 30 at 7:10 PM

$BFRI don't trap in the fake news. Only for creating a hype. License and supply agreement wasn't 35% as in the fake news . See 8-K filing date 2024-02-20.

0 · Reply

Bulltrader988 Jun. 30 at 6:50 PM

$BFRI 👃👀 https://www.tipranks.com/news/company-announcements/biofrontera-restructures-u-s-rights-with-11m-investment?utm_source=webullapp.com&utm_medium=referral

0 · Reply

Bulltrader988 Jun. 30 at 6:26 PM

$BFRI PT raised from $8 to $10 👃👀 https://www.tipranks.com/news/the-fly/biofrontera-inc-price-target-raised-to-10-from-8-at-roth-capital-thefly?utm_source=webullapp.com&utm_medium=referral

0 · Reply

Bulltrader988 Jun. 30 at 6:15 PM

$BFRI "...announced today that it has acquired all U.S. Rights to Ameluz® and RhodoLED® from its former parent company Biofrontera AG. An $11 million investment led by Rosalind Advisors, Inc. and AIGH Capital Management LLC funded the acquisition and transfer costs....". 👃👀 https://www.stocktitan.net/news/BFRI/biofrontera-inc-announces-major-restructuring-of-relationship-with-mxivwy3h909i.html

0 · Reply

Garlic1969 Jun. 30 at 4:21 PM

$BFRI let's see where she goes ...

0 · Reply

kcarroll92 Jun. 30 at 4:12 PM

$BFRI

0 · Reply

PharmaExpert Jun. 30 at 4:07 PM

$AKBA, $ARTL, $BFRI, $XTNT, $DNA 🔥🔥🔥🔥🔥

1 · Reply

ClenchFists Jun. 30 at 3:57 PM

$BFRI Going to $2!! Vnreal!!

0 · Reply

tushar0077 Jun. 30 at 3:57 PM

$BFRI lets get to that $1

0 · Reply

TeriusTheGreat Jun. 30 at 3:29 PM

$BFRI All this needs now is some volume , very good news , this should really go up , a bear short would not touch this one 😀!!

0 · Reply

tushar0077 Jun. 30 at 2:40 PM

$BFRI volume 👀

0 · Reply

ivo98 Jun. 30 at 1:14 PM

$BFRI more dilution and 12% will not help to be profitable in 2025. New cash will be burned by Q1 2026. They will hype the share price forthe investors. 🤗🤑🤣

0 · Reply

tushar0077 Jun. 30 at 1:09 PM

$BFRI primed to run hard

0 · Reply

Bulltrader988 Jun. 30 at 12:41 PM

$BFRI 👃👀 https://www.stocktitan.net/news/BFRI/biofrontera-inc-announces-major-restructuring-of-relationship-with-mxivwy3h909i.html

0 · Reply

Chucky91 Jun. 30 at 12:29 PM

$BFRI News out ! Ready to fly $ZVSA $ERAS $HCTI

0 · Reply

Market Cap	6.61M
Revenue (ttm)	37.32M
Net Income (ttm)	-17.76M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-47.59%
Debt to Equity Ratio	8.98

Volume	76,317
Avg Vol	189,200
Day's Range	N/A - N/A
Shares Out	9.45M
Stochastic %K	66%
Beta	0.43
Analysts	Strong Sell
Price Target	$6.38